Contribution of Nrf2 to Atherogenic Phenotype Switching of Coronary Arterial Smooth Muscle Cells Lacking CD38 Gene

Cellular Physiology and Biochemistry

Volumn 37, Issue 2, 2015, Pages 432-444

  Xu, Ming ^a,b   Li, Xiao Xue ^a   Wang, Lei ^a   Wang, Mi ^a   Zhang, Yang ^a,c   Li, Pin Lan ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b CHINA PHARMACEUTICAL UNIVERSITY   (China)

^c UNIVERSITY OF HOUSTON   (United States)

Author keywords

Atherogenesis; CD38; Dedifferentiation; Nrf2; Vascular smooth muscle

Indexed keywords

7 OXOCHOLESTEROL; ADENOSINE DIPHOSPHATE; ADENOSINE DIPHOSPHATE RIBOSYLCYCLASE; ALPHA SMOOTH MUSCLE ACTIN; CALCIUM ION; CALPONIN; NICOTINIC ACID ADENINE DINUCLEOTIDE PHOSPHATE; OXIDIZED LOW DENSITY LIPOPROTEIN; OXYGEN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; TRANSCRIPTION FACTOR NRF2; TRANSGELIN; UNCLASSIFIED DRUG; VIMENTIN; 7-KETOCHOLESTEROL; CALCIUM; CD38 ANTIGEN; CD38 PROTEIN, MOUSE; CHOLESTEROL DERIVATIVE; MEMBRANE PROTEIN; NFE2L2 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; CALCIUM CELL LEVEL; CD38 GENE; CELL DEDIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; CORONARY ARTERY MUSCLE; FEMALE; GENE; GENE EXPRESSION; GENE SILENCING; MALE; MOUSE; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PHENOTYPIC VARIATION; PRIMARY CULTURE; PRIORITY JOURNAL; UPREGULATION; VASCULAR SMOOTH MUSCLE CELL; ANIMAL; ATHEROSCLEROSIS; CELL CULTURE; CELL TRANSDIFFERENTIATION; CORONARY BLOOD VESSEL; CYTOLOGY; DEFICIENCY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; SMOOTH MUSCLE CELL; VASCULAR SMOOTH MUSCLE;

ANIMALS; ANTIGENS, CD38; ATHEROSCLEROSIS; CALCIUM; CELL PROLIFERATION; CELL TRANSDIFFERENTIATION; CELLS, CULTURED; CORONARY VESSELS; FEMALE; GENE EXPRESSION REGULATION; KETOCHOLESTEROLS; MALE; MEMBRANE GLYCOPROTEINS; MICE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS;

EID: 84940743420     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000430366     Document Type: Article

References (34)

1. Gomez D, Owens GK: Smooth muscle cell phenotypic switching in atherosclerosis. Cardiovasc Res 2012;95:156-164.
2. Zhang Y, Xu M, Xia M, Li X, Boini KM, Wang M, Gulbins E, Ratz PH, Li PL: Defective autophagosome trafficking contributes to impaired autophagic flux in coronary arterial myocytes lacking cd38 gene. Cardiovasc Res 2014;102:68-78.
3. Xu M, Li XX, Ritter JK, Abais JM, Zhang Y, Li PL: Contribution of nadph oxidase to membrane cd38 internalization and activation in coronary arterial myocytes. PloS one 2013;8:e71212.
4. Li PL, Zhang Y, Abais JM, Ritter JK, Zhang F: Cyclic adp-ribose and naadp in vascular regulation and diseases. Messenger 2013;2:63-85.
5. Wei WJ, Sun HY, Ting KY, Zhang LH, Lee HC, Li GR, Yue J: Inhibition of cardiomyocytes differentiation of mouse embryonic stem cells by cd38/cadpr/ca2+ signaling pathway. J Biol Chem 2012;287:35599-35611.
6. Nipp RD, Volkheimer AD, Davis ED, Chen Y, Weinberg JB, Friedman DR: Cd38 variation as a prognostic factor in chronic lymphocytic leukemia. Leuk Lymphoma 2014;55:191-194.
7. DeNicola GM, Karreth FA, Humpton TJ, Gopinathan A, Wei C, Frese K, Mangal D, Yu KH, Yeo CJ, Calhoun ES, Scrimieri F, Winter JM, Hruban RH, Iacobuzio-Donahue C, Kern SE, Blair IA, Tuveson DA: Oncogene-induced nrf2 transcription promotes ros detoxification and tumorigenesis. Nature 2011;475:106-109.
8. Gupte AA, Lyon CJ, Hsueh WA: Nuclear factor (erythroid-derived 2)-like-2 factor (nrf2), a key regulator of the antioxidant response to protect against atherosclerosis and nonalcoholic steatohepatitis. Curr Diab Rep 2013;13:362-371.
9. Freigang S, Ampenberger F, Spohn G, Heer S, Shamshiev AT, Kisielow J, Hersberger M, Yamamoto M, Bachmann MF, Kopf M: Nrf2 is essential for cholesterol crystal-induced inflammasome activation and exacerbation of atherosclerosis. Eur J Immunol 2011;41:2040-2051.
10. Hur KY, Kim SH, Choi MA, Williams DR, Lee YH, Kang SW, Yadav UC, Srivastava SK, Jung M, Cho JW, Kim SG, Kang ES, Lee EJ, Lee HC: Protective effects of magnesium lithospermate b against diabetic atherosclerosis via nrf2-are-nqo1 transcriptional pathway. Atherosclerosis 2010;211:69-76.
11. Dai G, Vaughn S, Zhang Y, Wang ET, Garcia-Cardena G, Gimbrone MA, Jr.: Biomechanical forces in atherosclerosis-resistant vascular regions regulate endothelial redox balance via phosphoinositol 3-kinase/akt-dependent activation of nrf2. Circ Res 2007;101:723-733.
12. Xu M, Zhang Y, Xia M, Li XX, Ritter JK, Zhang F, Li PL: Nad(p)h oxidase-dependent intracellular and extracellular o2-production in coronary arterial myocytes from cd38 knockout mice. Free Radic Biol Med 2012;52:357-365.
13. Teng B, Ansari HR, Oldenburg PJ, Schnermann J, Mustafa SJ: Isolation and characterization of coronary endothelial and smooth muscle cells from a1 adenosine receptor-knockout mice. Am J Physiol Heart Circ Physiol 2006;290:H1713-1720.
14. Xu M, Li XX, Chen Y, Pitzer AL, Zhang Y, Li PL: Enhancement of dynein-mediated autophagosome trafficking and autophagy maturation by ros in mouse coronary arterial myocytes. J Cell Mol Med 2014;18:2165-2175.
15. Devlin CM, Leventhal AR, Kuriakose G, Schuchman EH, Williams KJ, Tabas I: Acid sphingomyelinase promotes lipoprotein retention within early atheromata and accelerates lesion progression. Arterioscler Thromb Vasc Biol 2008;28:1723-1730.
16. Wang M, Abais JM, Meng N, Zhang Y, Ritter JK, Li PL, Tang WX: Upregulation of cannabinoid receptor-1 and fibrotic activation of mouse hepatic stellate cells during schistosoma j. Infection: Role of nadph oxidase. Free Radic Biol Med 2014;71:109-120.
17. Zhang F, Xia M, Li PL: Lysosome-dependent ca(2+) release response to fas activation in coronary arterial myocytes through naadp: Evidence from cd38 gene knockouts. Am J Physiol Cell Physiol 2010;298:C1209-1216.
18. Wanjare M, Kusuma S, Gerecht S: Perivascular cells in blood vessel regeneration. Biotechnol J 2013;8:434-447.
19. Doran AC, Meller N, McNamara CA: Role of smooth muscle cells in the initiation and early progression of atherosclerosis. Arterioscler Thromb Vasc Biol 2008;28:812-819.
20. Ding Y, Zhang B, Zhou K, Chen M, Wang M, Jia Y, Song Y, Li Y, Wen A: Dietary ellagic acid improves oxidantinduced endothelial dysfunction and atherosclerosis: Role of nrf2 activation. Int J Cardiol 2014;175:508-514.
21. Jayachandran M, Chandrasekaran B, Namasivayam N: Geraniol attenuates oxidative stress by nrf2 activation in diet-induced experimental atherosclerosis. J Basic Clin Physiol Pharmacol 2015;26:335-346.
22. Hosoya T, Maruyama A, Kang MI, Kawatani Y, Shibata T, Uchida K, Warabi E, Noguchi N, Itoh K, Yamamoto M: Differential responses of the nrf2-keap1 system to laminar and oscillatory shear stresses in endothelial cells. J Biol Chem 2005;280:27244-27250.
23. Sussan TE, Jun J, Thimmulappa R, Bedja D, Antero M, Gabrielson KL, Polotsky VY, Biswal S: Disruption of nrf2, a key inducer of antioxidant defenses, attenuates apoe-mediated atherosclerosis in mice. PloS one 2008;3:e3791.
24. Ashino T, Yamamoto M, Yoshida T, Numazawa S: Redox-sensitive transcription factor nrf2 regulates vascular smooth muscle cell migration and neointimal hyperplasia. Arterioscler Thromb Vasc Biol 2013;33:760-768.
25. Levonen AL, Inkala M, Heikura T, Jauhiainen S, Jyrkkanen HK, Kansanen E, Maatta K, Romppanen E, Turunen P, Rutanen J, Yla-Herttuala S: Nrf2 gene transfer induces antioxidant enzymes and suppresses smooth muscle cell growth in vitro and reduces oxidative stress in rabbit aorta in vivo. Arterioscler Thromb Vasc Biol 2007;27:741-747.
26. Reddy SP: The antioxidant response element and oxidative stress modifiers in airway diseases. Curr Mol Med 2008;8:376-383.
27. Griendling KK, Sorescu D, Ushio-Fukai M: Nad(p)h oxidase: Role in cardiovascular biology and disease. Circ Res 2000;86:494-501.
28. Zhang G, Zhang F, Muh R, Yi F, Chalupsky K, Cai H, Li PL: Autocrine/paracrine pattern of superoxide production through nad(p)h oxidase in coronary arterial myocytes. Am J Physiol Heart Circ Physiol 2007;292:H483-495.
29. Ahmad M, Kelly MR, Zhao X, Kandhi S, Wolin MS: Roles for nox4 in the contractile response of bovine pulmonary arteries to hypoxia. Am J Physiol Heart Circ Physiol 2010;298:H1879-1888.
30. Bryan HK, Olayanju A, Goldring CE, Park BK: The nrf2 cell defence pathway: Keap1-dependent and-independent mechanisms of regulation. Biochem Pharmacol 2013;85:705-717.
31. Xue J, Wang S, Wu J, Hannafon BN, Ding WQ: Zinc at sub-cytotoxic concentrations induces heme oxygenase-1 expression in human cancer cells. Cell Physiol Biochem 2013;32:100-110.
32. Wang C, Li C, Peng H, Ye Z, Zhang J, Liu X, Lou T: Activation of the nrf2-are pathway attenuates hyperglycemia-mediated injuries in mouse podocytes. Cell Physiol Biochem 2014;34:891-902.
33. Wang S, Hannafon BN, Zhou J, Ding WQ: Clofibrate induces heme oxygenase 1 expression through a pparalpha-independent mechanism in human cancer cells. Cell Physiol Biochem 2013;32:1255-1264.
34. Zhang F, Jin S, Yi F, Xia M, Dewey WL, Li PL: Local production of o2-by nad(p)h oxidase in the sarcoplasmic reticulum of coronary arterial myocytes: Cadpr-mediated ca2+ regulation. Cell Signal 2008;20:637-644.